A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study.

IF 3.7 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
International Journal of Medical Sciences Pub Date : 2026-05-18 eCollection Date: 2026-01-01 DOI:10.7150/ijms.133397
Hexia Gan, Jiana Jiang, Jiebin Yang, Feng Shen, Weihong Lu, Peng Lai, Lingyu Chen, Zhibing Xu, Jianping Zhang, Jianming Guo, Fan Chao
{"title":"A Hypoxia and Immune Escape-Related Gene Signature for the Diagnosis of Prostate Cancer: An Integrated Bioinformatics Study.","authors":"Hexia Gan, Jiana Jiang, Jiebin Yang, Feng Shen, Weihong Lu, Peng Lai, Lingyu Chen, Zhibing Xu, Jianping Zhang, Jianming Guo, Fan Chao","doi":"10.7150/ijms.133397","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer remains a major global health concern for men, with hypoxia and immune escape being key drivers of tumor progression; however, no reliable diagnostic signature integrating both processes has been established for clinical use. In this study, we integrated RNA sequencing and microarray data from The Cancer Genome Atlas (TCGA)-PRAD, Genotype-Tissue Expression (GTEx), and Gene Expression Omnibus (GEO) datasets to identify hypoxia and immune escape-related genes (HIERGs). Through differential expression analysis, functional enrichment, and machine learning algorithms including Random Forest, SVM-RFE, and LASSO regression, we constructed a robust six-gene diagnostic signature comprising <i>RBMS3</i>, <i>ALDH2</i>, <i>SLC7A11</i>, <i>FGFR2</i>, <i>GDF15</i>, and <i>NCAM1</i>. The model demonstrated high diagnostic accuracy, with area under the curve (AUC) values exceeding 0.9 across all validation cohorts, as confirmed by calibration curves, decision curve analysis, and receiver operating characteristic curves. Functional analysis revealed significant enrichment in translation-related pathways and smooth muscle contraction, and the RiskScore was significantly associated with altered immune cell infiltration in the tumor microenvironment. Regulatory network analysis further uncovered potential upstream regulators and therapeutic agents targeting the key genes. In conclusion, we developed and validated a hypoxia and immune escape-related gene signature with robust diagnostic performance for prostate cancer. Exploratory grouping by the model-derived RiskScore revealed differences in pathway and immune infiltration patterns, suggesting an association between the signature and intratumoral molecular heterogeneity. These exploratory findings primarily serve to characterize the biological features related to the model and provide supplementary clues for understanding molecular alterations in prostate cancer; they should be interpreted with caution.</p>","PeriodicalId":14031,"journal":{"name":"International Journal of Medical Sciences","volume":"23 7","pages":"2225-2251"},"PeriodicalIF":3.7000,"publicationDate":"2026-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13280752/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/ijms.133397","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Prostate cancer remains a major global health concern for men, with hypoxia and immune escape being key drivers of tumor progression; however, no reliable diagnostic signature integrating both processes has been established for clinical use. In this study, we integrated RNA sequencing and microarray data from The Cancer Genome Atlas (TCGA)-PRAD, Genotype-Tissue Expression (GTEx), and Gene Expression Omnibus (GEO) datasets to identify hypoxia and immune escape-related genes (HIERGs). Through differential expression analysis, functional enrichment, and machine learning algorithms including Random Forest, SVM-RFE, and LASSO regression, we constructed a robust six-gene diagnostic signature comprising RBMS3, ALDH2, SLC7A11, FGFR2, GDF15, and NCAM1. The model demonstrated high diagnostic accuracy, with area under the curve (AUC) values exceeding 0.9 across all validation cohorts, as confirmed by calibration curves, decision curve analysis, and receiver operating characteristic curves. Functional analysis revealed significant enrichment in translation-related pathways and smooth muscle contraction, and the RiskScore was significantly associated with altered immune cell infiltration in the tumor microenvironment. Regulatory network analysis further uncovered potential upstream regulators and therapeutic agents targeting the key genes. In conclusion, we developed and validated a hypoxia and immune escape-related gene signature with robust diagnostic performance for prostate cancer. Exploratory grouping by the model-derived RiskScore revealed differences in pathway and immune infiltration patterns, suggesting an association between the signature and intratumoral molecular heterogeneity. These exploratory findings primarily serve to characterize the biological features related to the model and provide supplementary clues for understanding molecular alterations in prostate cancer; they should be interpreted with caution.

前列腺癌诊断中的缺氧和免疫逃逸相关基因标记:一项综合生物信息学研究。
前列腺癌仍然是全球男性的主要健康问题,缺氧和免疫逃逸是肿瘤进展的关键驱动因素;然而,没有可靠的诊断签名整合这两个过程已建立临床应用。在这项研究中,我们整合了来自癌症基因组图谱(TCGA)-PRAD、基因型-组织表达(GTEx)和基因表达综合(GEO)数据集的RNA测序和微阵列数据,以鉴定缺氧和免疫逃逸相关基因(HIERGs)。通过差异表达分析、功能富集和机器学习算法,包括随机森林、SVM-RFE和LASSO回归,我们构建了一个包含RBMS3、ALDH2、SLC7A11、FGFR2、GDF15和NCAM1的稳健的六基因诊断签名。校准曲线、决策曲线分析和受试者工作特征曲线证实,该模型具有较高的诊断准确性,所有验证队列的曲线下面积(AUC)值均超过0.9。功能分析显示,翻译相关通路和平滑肌收缩显著富集,RiskScore与肿瘤微环境中免疫细胞浸润的改变显著相关。调控网络分析进一步揭示了潜在的上游调控因子和靶向关键基因的治疗剂。总之,我们开发并验证了一个缺氧和免疫逃逸相关的基因标记,对前列腺癌具有强大的诊断性能。通过模型衍生的RiskScore探索性分组揭示了途径和免疫浸润模式的差异,表明该特征与肿瘤内分子异质性之间存在关联。这些探索性发现主要用于描述与模型相关的生物学特征,并为理解前列腺癌的分子改变提供补充线索;对它们的解读应谨慎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Medical Sciences
International Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
7.20
自引率
0.00%
发文量
185
审稿时长
2.7 months
期刊介绍: Original research papers, reviews, and short research communications in any medical related area can be submitted to the Journal on the understanding that the work has not been published previously in whole or part and is not under consideration for publication elsewhere. Manuscripts in basic science and clinical medicine are both considered. There is no restriction on the length of research papers and reviews, although authors are encouraged to be concise. Short research communication is limited to be under 2500 words.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书